pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,788 catalysts · 4,779 phase readout · 2,339 8k filing · 285 earnings · 271 pdufa · 166 phase 2 completion · 71 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 0 catalysts2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: patent expiry×type: phase readout×clear all
type
  • phase readout4,779
  • 8k filing2,339
  • earnings285
  • pdufa271
  • phase 2 completion166
  • phase 1 completion71
phase 2 initiation
54
  • phase 1 initiation39
  • phase 1 2 completion33
  • phase 0 trial completion23
  • therapy area
    • Infectious Disease7
    • Dermatology1
    • Oncology1

    Date TBD

    50
    ›NOT_YET_RECRUITINGphase readoutNCT07580469: Platelets and Extracorporeal Membrane Oxygenation Veno-venous

    Sponsor: University Hospital, Toulouse. Phase: . Conditions: Extracorporeal Membrane Oxygenation Complication, Hemorrhage, Blood Platelet Disorder, Thrombosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06309069: Calcified Cerebral Embolism: a Descriptive Study in a Large Single Center Cohort

    Sponsor: Centre Hospitalier Universitaire de Nīmes. Phase: . Conditions: Calcified Cerebral Embolism

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06864169: A Study of Raludotatug Deruxtecan (R-DXd) in People With Gastrointestinal Cancers (MK-5909-005)

    Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE2. Conditions: Gastrointestinal Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04344769: Characterization of the Nrf2 Response in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

    Sponsor: Mayo Clinic. Phase: . Conditions: Autosomal Dominant Polycystic Kidney Disease

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06263283: Impact of an Educational Physiotherapy-Yoga Intervention on Perceived Stress in Women Treated With Brachytherapy for Cervical Cancer

    Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle. Phase: NA. Conditions: Cervical Cancer, Brachytherapy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04944394: Psychological and Ethical Support for Hospital Professionals During the COVID-19 Pandemic: Suitability and Post-crisis Implications for the Experience of All Professionals

    Sponsor: Centre Hospitalier Universitaire Dijon. Phase: . Conditions: Psychological Stress

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03030066: Study of DS-1001b in Patients With Gene IDH1-Mutated Gliomas

    Sponsor: Daiichi Sankyo. Phase: PHASE1. Conditions: Glioma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05158166: DaxibotulinumtoxinA Injection for Treatment of Adductor Spasmodic Dysphonia

    Sponsor: University of California, San Francisco. Phase: PHASE1. Conditions: Adductor Spasmodic Dysphonia, Voice Disorders, Spasmodic Dysphonia

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05691166: Reducing Falls With Progressive Resistance Training for the Oldest Old Adults With Sarcopenia

    Sponsor: Norwegian University of Science and Technology. Phase: NA. Conditions: Sarcopenia, Aging

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07126951: Pilot Study: Clinical Trial of Ultrasound Guiding Pharmacopuncture Therapy for Acute Low Back Pain

    Sponsor: Jaseng Medical Foundation. Phase: NA. Conditions: Low Back Pain (LBP)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07499531: The Effect of Pulse Field Ablation of Atrial Fibrillation Involving Posterior Wall Ablation on Atrial Mechancis Assessed by Cardiac Magnetic Resonance Imaging

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Persistant Atrial Fibrillation, Paroxysmal AF

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06861595: Using the Accuvein Device for Patients Who Are Difficult to Perfuse

    Sponsor: University Hospital, Rouen. Phase: NA. Conditions: Patient Who Are Difficult to Infuse

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06626295: Exercise-snacks for Breaking the Sedentary Lifestyle and Improving the Physical Fitness of Obese Adolescents?

    Sponsor: University of Avignon. Phase: NA. Conditions: Obese Adolescents, Sedentary Time, Exercise

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05709977: Acupuncture for Nasal Congestion in Allergic Rhinitis

    Sponsor: Johanna Maria Vermeulen. Phase: NA. Conditions: Allergic Rhinitis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06701877: Enhancing Foster Care Relationships Through Attachment-Based Intervention: Protocol of SAFE FAMILY STUDY

    Sponsor: Shankland Rebecca. Phase: NA. Conditions: Parenting Sensitivity, Foster Care

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07329777: Atropine in the Treatment of Myopia Study in Malaysia

    Sponsor: IDB VisionCare SDN BHD. Phase: PHASE3. Conditions: Myopia Progression

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07386977: Effects of Visual Feedback on Angular Error

    Sponsor: Lokman Hekim University. Phase: . Conditions: Knee Osteoarthritis, Gonarthrosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05410977: Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients

    Sponsor: Mayo Clinic. Phase: . Conditions: Colorectal Carcinoma, Lynch Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04159675: Burosumab and 1-25 (OH) Vitamin D on Human Osteoblasts

    Sponsor: Hospices Civils de Lyon. Phase: . Conditions: Craniosynostoses

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06754501: A Phase 2 Clinical Trial Evaluating the Efficacy and Safety of Dual Immune Checkpoint Inhibition With Anti-PD-L1 (Atezolizumab) and Anti-TIGIT (Tiragolumab) in Cancer of Unknown Primary

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07305779: A Trial to Test the Effects of Other Drugs on SEP-380135 in Healthy Men and Women

    Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.. Phase: PHASE1. Conditions: Schizophrenia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07481396: Molecular Insights Into Post-Cardiac Arrest Brain Injury Via CSF Multi-Omics

    Sponsor: Chungnam National University Hospital. Phase: . Conditions: Cardiac Arrest (CA), Cerebrospinal Fluid, Multiomics, Hypoxic-Ischemic Brain Injury

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06650488: Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus Bacteremia

    Sponsor: Todd C. Lee MD MPH FIDSA. Phase: PHASE4. Conditions: Staphylococcus Aureus Endocarditis, Staphylococcus Aureus Septicemia, Staphylococcus Aureus Bloodstream Infection

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07501988: The Effect Of Color Rotation Technique Training On İnsülin Self-management İn Diabetic Patients.

    Sponsor: Tokat Gaziosmanpasa University. Phase: NA. Conditions: Diabete Mellitus, İnsulin Self-management

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07487688: Five-Year CT Follow-Up of Vertebral Fracture Risk Using Opportunistic Osteoporosis Screening

    Sponsor: Technical University of Munich. Phase: . Conditions: Osteoporosis, Fracture Risk Assessment, Osteoporotic Fracture of Vertebra

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06821503: Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C

    Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Phase: PHASE1. Conditions: Advanced Pancreatic Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03895203: A Study to Test the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis

    Sponsor: UCB Biopharma SRL. Phase: PHASE3. Conditions: Psoriatic Arthritis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07482527: Thoracic Mobility Versus Hip Mobility Exercises to Core Stabilization in Lumbar Spondylitis

    Sponsor: Cairo University. Phase: NA. Conditions: Individuals With Lumbar Spondylosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06561386: A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

    Sponsor: Bristol-Myers Squibb. Phase: PHASE3. Conditions: Non-small Cell Lung Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07174986: Early Double Sequential Defibrillation in Out of Hospital Cardiac Arrest

    Sponsor: Gabriel Riva. Phase: PHASE2. Conditions: Out of Hospital Cardiac Arrest, Ventricular Fibrillation, Defibrillation, CPR, ACLS, Sudden Death

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07500870: Comparative Evaluation of Endodontic Instrumentation Kinematics and Cryotherapy on Post-endodontic Pain and Periapical Healing

    Sponsor: All India Institute of Medical Sciences. Phase: NA. Conditions: Post Endodontic Pain, Periapical Healing

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06247670: Study of CMP-CPS-001 in Healthy Volunteers and Participants With Abnormal Heterozygous OTC Genotype

    Sponsor: CAMP4 Therapeutics Corporation. Phase: PHASE1. Conditions: Healthy Volunteers, OTC Deficiency

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06016842: A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis

    Sponsor: Ipsen. Phase: PHASE3. Conditions: Primary Biliary Cholangitis (PBC)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06792786: A Multicenter Prospective Study Evaluating Concurrent Chemoradiotherapy Following Induction Immunochemotherapy for Esophageal Cancer Based on Dynamic ctDNA Monitoring

    Sponsor: The Central Hospital of Lishui City. Phase: NA. Conditions: Esophageal Cancer, ctDNA

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07557186: Validity and Reliability of Kinovea Software Measurement of Lumbar Extensibility Using Modified-Modified Schober Test

    Sponsor: Cairo University. Phase: . Conditions: Lumbar Extensibility

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06710769: Ovarian Tissue Cryopreservation

    Sponsor: Phoenix Children's Hospital. Phase: NA. Conditions: Infertility, Female

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07420283: A Study of Brenipatide in Participants With Opioid Use Disorder

    Sponsor: Eli Lilly and Company. Phase: PHASE2. Conditions: Opioid Use Disorder

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07576569: Nursing Intervention for Adaptation After Myocardial Revascularization

    Sponsor: Universidad de la Sabana. Phase: NA. Conditions: Coronary Artery Disease, Myocardial Revascularization, Postoperative Recovery After Cardiac Surgery, Nursing Care

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07347054: Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Shoulder Osteoarthritis(OA)

    Sponsor: Beijing Tiantan Hospital. Phase: NA. Conditions: Myofascial Trigger Points, Chronic Musculoskeletal Pain, Shoulder Osteoarthritis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06514794: A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

    Sponsor: Wugen, Inc.. Phase: PHASE2. Conditions: T-cell Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05826366: Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - CEI/SCEI

    Sponsor: AstraZeneca. Phase: . Conditions: Carcinoma, Non-Small-Cell Lung

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03850366: HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib

    Sponsor: Henry Ford Health System. Phase: PHASE2. Conditions: Hematological Malignancy

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07516366: Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT Trial

    Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Clear Cell Renal Cell Carcinoma, Stage II Renal Cell Cancer AJCC v8, Stage III Renal Cell Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07249684: Myofascial Release And Static Stretching Along With Nighttime Bracing

    Sponsor: Riphah International University. Phase: NA. Conditions: Clubfoot Deformity

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT06868784: Investigation of the Relationship Between Executive Functions and Occupational Performance of Children With Duchenne Muscular Dystrophy

    Sponsor: Lokman Hekim University. Phase: . Conditions: Executive Dysfunction, Occupational Problems, Duchenne Muscular Dystrophy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07442084: Efficacy of Modified Si Ni San in Post-Polypectomy Management and Its Impact on Gut Microbiota in Colorectal Polyp Patients

    Sponsor: Xi'an Hospital of Traditional Chinese Medicine. Phase: NA. Conditions: Colorectal Polyps, Modified SiNiSan

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03988933: 2R2: Higher Dose Rifampin for 2 Months vs Standard Dose Rifampin for Latent TB.

    Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre. Phase: PHASE2. Conditions: Latent Tuberculosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05253352: Mapping and Quantifying Lymphatic Drainage of the Arm's Alternate Pathway

    Sponsor: Beth Israel Deaconess Medical Center. Phase: . Conditions: Lymphatic System

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07220252: Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of Multiple Sclerosis

    Sponsor: TG Therapeutics, Inc.. Phase: PHASE2. Conditions: Relapsing Multiple Sclerosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05269238: Improvement of the Performance of Lumbar Punctures After Training Students With an Augmented Reality SIMulator

    Sponsor: University Hospital, Strasbourg, France. Phase: NA. Conditions: Lumbar Puncture

    full page →ctgov ↗
    ← prev
    page 28 of 96
    next →